|
1.陳勁初、呂鋒洲, 靈芝之王:台灣樟芝. In 台灣, 2001; pp 50-190. 2.蘇慶華, 健康的守護神-國寶樟芝. 台北,台灣, 2002. 3.Hseu, Y. C.; Chen, S. C.; Tsai, P. C.; Chen, C. S.; Lu, F. J.; Chang, N. W.; Yang, H. L., Inhibition of cyclooxygenase-2 and induction of apoptosis in estrogen-nonresponsive breast cancer cells by Antrodia camphorata. Food Chem Toxicol 2007, 45, (7), 1107-15. 4.Hsu, Y. L.; Kuo, Y. C.; Kuo, P. L.; Ng, L. T.; Kuo, Y. H.; Lin, C. C., Apoptotic effects of extract from Antrodia camphorata fruiting bodies in human hepatocellular carcinoma cell lines. Cancer Lett 2005, 221, (1), 77-89. 5.Liu, J. J.; Huang, T. S.; Hsu, M. L.; Chen, C. C.; Lin, W. S.; Lu, F. J.; Chang, W. H., Antitumor effects of the partially purified polysaccharides from Antrodia camphorata and the mechanism of its action. Toxicol Appl Pharmacol 2004, 201, (2), 186-93. 6.Rao, Y. K.; Fang, S. H.; Tzeng, Y. M., Evaluation of the anti-inflammatory and anti-proliferation tumoral cells activities of Antrodia camphorata, Cordyceps sinensis, and Cinnamomum osmophloeum bark extracts. J Ethnopharmacol 2007, 114, (1), 78-85. 7.Song, T. Y.; Hsu, S. L.; Yeh, C. T.; Yen, G. C., Mycelia from Antrodia camphorata in Submerged culture induce apoptosis of human hepatoma HepG2 cells possibly through regulation of Fas pathway. J Agric Food Chem 2005, 53, (14), 5559-64. 8.Song, T. Y.; Hsu, S. L.; Yen, G. C., Induction of apoptosis in human hepatoma cells by mycelia of Antrodia camphorata in submerged culture. J Ethnopharmacol 2005, 100, (1-2), 158-67. 9.Yang, H. L.; Chen, C. S.; Chang, W. H.; Lu, F. J.; Lai, Y. C.; Chen, C. C.; Hseu, T. H.; Kuo, C. T.; Hseu, Y. C., Growth inhibition and induction of apoptosis in MCF-7 breast cancer cells by Antrodia camphorata. Cancer Lett 2006, 231, (2), 215-27. 10.Chen, C. C.; Liu, Y. W.; Ker, Y. B.; Wu, Y. Y.; Lai, E. Y.; Chyau, C. C.; Hseu, T. H.; Peng, R. Y., Chemical characterization and anti-inflammatory effect of polysaccharides fractionated from submerge-cultured Antrodia camphorata mycelia. J Agric Food Chem 2007, 55, (13), 5007-12. 11.Lee, I. H.; Huang, R. L.; Chen, C. T.; Chen, H. C.; Hsu, W. C.; Lu, M. K., Antrodia camphorata polysaccharides exhibit anti-hepatitis B virus effects. FEMS Microbiol Lett 2002, 209, (1), 63-7. 12.Shen, Y. C.; Chou, C. J.; Wang, Y. H.; Chen, C. F.; Chou, Y. C.; Lu, M. K., Anti-inflammatory activity of the extracts from mycelia of Antrodia camphorata cultured with water-soluble fractions from five different Cinnamomum species. FEMS Microbiol Lett 2004, 231, (1), 137-43. 13.Wu, Y. Y.; Chen, C. C.; Chyau, C. C.; Chung, S. Y.; Liu, Y. W., Modulation of inflammation-related genes of polysaccharides fractionated from mycelia of medicinal basidiomycete Antrodia camphorata. Acta Pharmacol Sin 2007, 28, (2), 258-67. 14.Akihisa, T.; Tokuda, H.; Ichiishi, E.; Mukainaka, T.; Toriumi, M.; Ukiya, M.; Yasukawa, K.; Nishino, H., Anti-tumor promoting effects of multiflorane-type triterpenoids and cytotoxic activity of karounidiol against human cancer cell lines. Cancer Lett 2001, 173, (1), 9-14. 15.Fukuda, Y.; Sakai, K.; Matsunaga, S.; Tokuda, H.; Tanaka, R., Cancer chemopreventive activity of lupane- and oleanane-type triterpenoids from the cones of Liquidamber styraciflua. Chem Biodivers 2005, 2, (3), 421-8. 16.Huang, M. T.; Badmaev, V.; Ding, Y.; Liu, Y.; Xie, J. G.; Ho, C. T., Anti-tumor and anti-carcinogenic activities of triterpenoid, beta-boswellic acid. Biofactors 2000, 13, (1-4), 225-30. 17.Lee, M. K.; Ha, N. R.; Yang, H.; Sung, S. H.; Kim, G. H.; Kim, Y. C., Antiproliferative activity of triterpenoids from Eclipta prostrata on hepatic stellate cells. Phytomedicine 2007. 18.Poulose, S. M.; Harris, E. D.; Patil, B. S., Antiproliferative effects of citrus limonoids against human neuroblastoma and colonic adenocarcinoma cells. Nutr Cancer 2006, 56, (1), 103-12. 19.Daval, J. L.; Nicolas, F.; Doriat, J. F., Adenosine physiology and pharmacology: how about A2 receptors? Pharmacol Ther 1996, 71, (3), 325-35. 20.Daval, J. L.; Nehlig, A.; Nicolas, F., Physiological and pharmacological properties of adenosine: therapeutic implications. Life Sci 1991, 49, (20), 1435-53. 21.Cronstein, B. N., Adenosine, an endogenous anti-inflammatory agent. J Appl Physiol 1994, 76, (1), 5-13. 22.Janier, M. F.; Vanoverschelde, J. L.; Bergmann, S. R., Adenosine protects ischemic and reperfused myocardium by receptor-mediated mechanisms. Am J Physiol 1993, 264, (1 Pt 2), H163-70. 23.Szabo, C.; Scott, G. S.; Virag, L.; Egnaczyk, G.; Salzman, A. L.; Shanley, T. P.; Hasko, G., Suppression of macrophage inflammatory protein (MIP)-1alpha production and collagen-induced arthritis by adenosine receptor agonists. Br J Pharmacol 1998, 125, (2), 379-87. 24.Bowlin, T. L.; Borcherding, D. R.; Edwards, C. K., 3rd; McWhinney, C. D., Adenosine A3 receptor agonists inhibit murine macrophage tumor necrosis factor-alpha production in vitro and in vivo. Cell Mol Biol (Noisy-le-grand) 1997, 43, (3), 345-9. 25.McWhinney, C. D.; Dudley, M. W.; Bowlin, T. L.; Peet, N. P.; Schook, L.; Bradshaw, M.; De, M.; Borcherding, D. R.; Edwards, C. K., 3rd, Activation of adenosine A3 receptors on macrophages inhibits tumor necrosis factor-alpha. Eur J Pharmacol 1996, 310, (2-3), 209-16. 26.Bouma, M. G.; van den Wildenberg, F. A.; Buurman, W. A., Adenosine inhibits cytokine release and expression of adhesion molecules by activated human endothelial cells. Am J Physiol 1996, 270, (2 Pt 1), C522-9. 27.de la Harpe, J.; Nathan, C. F., Adenosine regulates the respiratory burst of cytokine-triggered human neutrophils adherent to biologic surfaces. J Immunol 1989, 143, (2), 596-602. 28.Sullivan, G. W.; Linden, J.; Hewlett, E. L.; Carper, H. T.; Hylton, J. B.; Mandell, G. L., Adenosine and related compounds counteract tumor necrosis factor-alpha inhibition of neutrophil migration: implication of a novel cyclic AMP-independent action on the cell surface. J Immunol 1990, 145, (5), 1537-44. 29.Liu, J. S.; John, G. R.; Sikora, A.; Lee, S. C.; Brosnan, C. F., Modulation of interleukin-1beta and tumor necrosis factor alpha signaling by P2 purinergic receptors in human fetal astrocytes. J Neurosci 2000, 20, (14), 5292-9. 30.Sembries, S.; Pahl, H.; Stilgenbauer, S.; Dohner, H.; Schriever, F., Reduced expression of adhesion molecules and cell signaling receptors by chronic lymphocytic leukemia cells with 11q deletion. Blood 1999, 93, (2), 624-31. 31.John, G. R.; Simpson, J. E.; Woodroofe, M. N.; Lee, S. C.; Brosnan, C. F., Extracellular nucleotides differentially regulate interleukin-1beta signaling in primary human astrocytes: implications for inflammatory gene expression. J Neurosci 2001, 21, (12), 4134-42. 32.Majumdar, S.; Aggarwal, B. B., Adenosine suppresses activation of nuclear factor-kappaB selectively induced by tumor necrosis factor in different cell types. Oncogene 2003, 22, (8), 1206-18. 33.Rounds, S.; Yee, W. L.; Dawicki, D. D.; Harrington, E.; Parks, N.; Cutaia, M. V., Mechanism of extracellular ATP- and adenosine-induced apoptosis of cultured pulmonary artery endothelial cells. Am J Physiol 1998, 275, (2 Pt 1), L379-88. 34.Wu, L. F.; Li, G. P.; Feng, J. L.; Pu, Z. J., Molecular mechanisms of adenosine-induced apoptosis in human HepG2 cells. Acta Pharmacol Sin 2006, 27, (4), 477-84. 35.Yang, D.; Yaguchi, T.; Yamamoto, H.; Nishizaki, T., Intracellularly transported adenosine induces apoptosis in HuH-7 human hepatoma cells by downregulating c-FLIP expression causing caspase-3/-8 activation. Biochem Pharmacol 2007, 73, (10), 1665-75. 36.Saitoh, M.; Nagai, K.; Nakagawa, K.; Yamamura, T.; Yamamoto, S.; Nishizaki, T., Adenosine induces apoptosis in the human gastric cancer cells via an intrinsic pathway relevant to activation of AMP-activated protein kinase. Biochem Pharmacol 2004, 67, (10), 2005-11. 37.Stoltzfus, C. M.; Shatkin, A. J.; Banerjee, A. K., Absence of polyadenylic acid from reovirus messenger ribonucleic acid. J Biol Chem 1973, 248, (23), 7993-8. 38.Richardson, L. S.; Ting, R. C.; Gallo, R. C.; Wu, A. M., Effect of cordycepin on the replication of type-c RNA tumor viruses. Int J Cancer 1975, 15, (3), 451-6. 39.Thomadaki, H.; Tsiapalis, C. M.; Scorilas, A., Polyadenylate polymerase modulations in human epithelioid cervix and breast cancer cell lines, treated with etoposide or cordycepin, follow cell cycle rather than apoptosis induction. Biol Chem 2005, 386, (5), 471-80. 40.Sugar, A. M.; McCaffrey, R. P., Antifungal activity of 3'-deoxyadenosine (cordycepin). Antimicrob Agents Chemother 1998, 42, (6), 1424-7. 41.de Julian-Ortiz, J. V.; Galvez, J.; Munoz-Collado, C.; Garcia-Domenech, R.; Gimeno-Cardona, C., Virtual combinatorial syntheses and computational screening of new potential anti-herpes compounds. J Med Chem 1999, 42, (17), 3308-14. 42.Zhou, X.; Meyer, C. U.; Schmidtke, P.; Zepp, F., Effect of cordycepin on interleukin-10 production of human peripheral blood mononuclear cells. Eur J Pharmacol 2002, 453, (2-3), 309-17. 43.Koc, Y.; Urbano, A. G.; Sweeney, E. B.; McCaffrey, R., Induction of apoptosis by cordycepin in ADA-inhibited TdT-positive leukemia cells. Leukemia 1996, 10, (6), 1019-24. 44.Kobori, M.; Yoshida, M.; Ohnishi-Kameyama, M.; Shinmoto, H., Ergosterol peroxide from an edible mushroom suppresses inflammatory responses in RAW264.7 macrophages and growth of HT29 colon adenocarcinoma cells. Br J Pharmacol 2007, 150, (2), 209-19. 45.Kim, J. A.; Tay, D.; Blanco, E. C., NF-kappaB inhibitory activity of compounds isolated from Cantharellus cibarius. Phytother Res 2008. 46.Takei, T.; Yoshida, M.; Ohnishi-Kameyama, M.; Kobori, M., Ergosterol peroxide, an apoptosis-inducing component isolated from Sarcodon aspratus (Berk.) S. Ito. Biosci Biotechnol Biochem 2005, 69, (1), 212-5. 47.Bok, J. W.; Lermer, L.; Chilton, J.; Klingeman, H. G.; Towers, G. H., Antitumor sterols from the mycelia of Cordyceps sinensis. Phytochemistry 1999, 51, (7), 891-8. 48.Yasukawa, K.; Takahashi, M.; Natori, S.; Kawai, K.; Yamazaki, M.; Takeuchi, M.; Takido, M., Azaphilones inhibit tumor promotion by 12-O-tetradecanoylphorbol-13-acetate in two-stage carcinogenesis in mice. Oncology 1994, 51, (1), 108-12. 49.Kinoshita, T.; Nakanishi, I.; Terasaka, T.; Kuno, M.; Seki, N.; Warizaya, M.; Matsumura, H.; Inoue, T.; Takano, K.; Adachi, H.; Mori, Y.; Fujii, T., Structural basis of compound recognition by adenosine deaminase. Biochemistry 2005, 44, (31), 10562-9. 50.Kitajma, Y., [Structural and biochemical characteristics of pathogenic fungus: cell walls, lipids and dimorphism, and action modes of antifungal agents]. Nippon Ishinkin Gakkai Zasshi 2000, 41, (4), 211-7. 51.Yoshikawa, N.; Yamada, S.; Takeuchi, C.; Kagota, S.; Shinozuka, K.; Kunitomo, M.; Nakamura, K., Cordycepin (3'-deoxyadenosine) inhibits the growth of B16-BL6 mouse melanoma cells through the stimulation of adenosine A3 receptor followed by glycogen synthase kinase-3beta activation and cyclin D1 suppression. Naunyn Schmiedebergs Arch Pharmacol 2008, 377, (4-6), 591-5. 52.Schwacha, M. G., Macrophages and post-burn immune dysfunction. Burns 2003, 29, (1), 1-14. 53.Qureshi, M. A.; Hill, C. H.; Heggen, C. L., Vanadium stimulates immunological responses of chicks. Vet Immunol Immunopathol 1999, 68, (1), 61-71. 54.Rietschel, E. T.; Kirikae, T.; Schade, F. U.; Mamat, U.; Schmidt, G.; Loppnow, H.; Ulmer, A. J.; Zahringer, U.; Seydel, U.; Di Padova, F.; et al., Bacterial endotoxin: molecular relationships of structure to activity and function. FASEB J 1994, 8, (2), 217-25. 55.Gallay, P.; Heumann, D.; Le Roy, D.; Barras, C.; Glauser, M. P., Mode of action of anti-lipopolysaccharide-binding protein antibodies for prevention of endotoxemic shock in mice. Proc Natl Acad Sci U S A 1994, 91, (17), 7922-6. 56.Nogare, A. R.; Yarbrough, W. C., Jr., A comparison of the effects of intact and deacylated lipopolysaccharide on human polymorphonuclear leukocytes. J Immunol 1990, 144, (4), 1404-10. 57.Barnes, P. J., Nuclear factor-kappa B. Int J Biochem Cell Biol 1997, 29, (6), 867-70. 58.Verma, I. M.; Stevenson, J. K.; Schwarz, E. M.; Van Antwerp, D.; Miyamoto, S., Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation. Genes Dev 1995, 9, (22), 2723-35. 59.Karin, M., The beginning of the end: IkappaB kinase (IKK) and NF-kappaB activation. J Biol Chem 1999, 274, (39), 27339-42. 60.Karin, M., How NF-kappaB is activated: the role of the IkappaB kinase (IKK) complex. Oncogene 1999, 18, (49), 6867-74. 61.Yamaoka, S.; Courtois, G.; Bessia, C.; Whiteside, S. T.; Weil, R.; Agou, F.; Kirk, H. E.; Kay, R. J.; Israel, A., Complementation cloning of NEMO, a component of the IkappaB kinase complex essential for NF-kappaB activation. Cell 1998, 93, (7), 1231-40. 62.Miyamoto, S.; Verma, I. M., Rel/NF-kappa B/I kappa B story. Adv Cancer Res 1995, 66, 255-92. 63.Graziewicz, M.; Wink, D. A.; Laval, F., Nitric oxide inhibits DNA ligase activity: potential mechanisms for NO-mediated DNA damage. Carcinogenesis 1996, 17, (11), 2501-5. 64.Goodlett, C. R.; Horn, K. H., Mechanisms of alcohol-induced damage to the developing nervous system. Alcohol Res Health 2001, 25, (3), 175-84. 65.Klose, J.; Kobalz, U., Two-dimensional electrophoresis of proteins: an updated protocol and implications for a functional analysis of the genome. Electrophoresis 1995, 16, (6), 1034-59. 66.Spiegel, A., Cell signaling. beta-arrestin--not just for G protein-coupled receptors. Science 2003, 301, (5638), 1338-9. 67.Lefkowitz, R. J.; Rajagopal, K.; Whalen, E. J., New roles for beta-arrestins in cell signaling: not just for seven-transmembrane receptors. Mol Cell 2006, 24, (5), 643-52. 68.Wei, C. Y.; Huang, K. C.; Chou, Y. H.; Hsieh, P. F.; Lin, K. H.; Lin, W. W., The role of Rho-associated kinase in differential regulation by statins of interleukin-1beta- and lipopolysaccharide-mediated nuclear factor kappaB activation and inducible nitric-oxide synthase gene expression in vascular smooth muscle cells. Mol Pharmacol 2006, 69, (3), 960-7. 69.Dovas, A.; Couchman, J. R., RhoGDI: multiple functions in the regulation of Rho family GTPase activities. Biochem J 2005, 390, (Pt 1), 1-9. 70.Olofsson, B., Rho guanine dissociation inhibitors: pivotal molecules in cellular signalling. Cell Signal 1999, 11, (8), 545-54. 71.Rattan, R.; Giri, S.; Singh, A. K.; Singh, I., Rho A negatively regulates cytokine-mediated inducible nitric oxide synthase expression in brain-derived transformed cell lines: negative regulation of IKKalpha. Free Radic Biol Med 2003, 35, (9), 1037-50. 72.Hseu, Y. C.; Wu, F. Y.; Wu, J. J.; Chen, J. Y.; Chang, W. H.; Lu, F. J.; Lai, Y. C.; Yang, H. L., Anti-inflammatory potential of Antrodia Camphorata through inhibition of iNOS, COX-2 and cytokines via the NF-kappaB pathway. Int Immunopharmacol 2005, 5, (13-14), 1914-25. 73.Liu, D. Z.; Liang, H. J.; Chen, C. H.; Su, C. H.; Lee, T. H.; Huang, C. T.; Hou, W. C.; Lin, S. Y.; Zhong, W. B.; Lin, P. J.; Hung, L. F.; Liang, Y. C., Comparative anti-inflammatory characterization of wild fruiting body, liquid-state fermentation, and solid-state culture of Taiwanofungus camphoratus in microglia and the mechanism of its action. J Ethnopharmacol 2007, 113, (1), 45-53. 74.Jijon, H. B.; Walker, J.; Hoentjen, F.; Diaz, H.; Ewaschuk, J.; Jobin, C.; Madsen, K. L., Adenosine is a negative regulator of NF-kappaB and MAPK signaling in human intestinal epithelial cells. Cell Immunol 2005, 237, (2), 86-95. 75.Kim, H. G.; Shrestha, B.; Lim, S. Y.; Yoon, D. H.; Chang, W. C.; Shin, D. J.; Han, S. K.; Park, S. M.; Park, J. H.; Park, H. I.; Sung, J. M.; Jang, Y.; Chung, N.; Hwang, K. C.; Kim, T. W., Cordycepin inhibits lipopolysaccharide-induced inflammation by the suppression of NF-kappaB through Akt and p38 inhibition in RAW 264.7 macrophage cells. Eur J Pharmacol 2006, 545, (2-3), 192-9. 76.Muller, W. E.; Seibert, G.; Beyer, R.; Breter, H. J.; Maidhof, A.; Zahn, R. K., Effect of cordycepin on nucleic acid metabolism in L5178Y cells and on nucleic acid-synthesizing enzyme systems. Cancer Res 1977, 37, (10), 3824-33. 77.Thomadaki, H.; Tsiapalis, C. M.; Scorilas, A., The effect of the polyadenylation inhibitor cordycepin on human Molt-4 and Daudi leukaemia and lymphoma cell lines. Cancer Chemother Pharmacol 2008, 61, (4), 703-11. 78.Pratt, W. B.; Toft, D. O., Regulation of signaling protein function and trafficking by the hsp90/hsp70-based chaperone machinery. Exp Biol Med (Maywood) 2003, 228, (2), 111-33. 79.Blagosklonny, M. V., Hsp-90-associated oncoproteins: multiple targets of geldanamycin and its analogs. Leukemia 2002, 16, (4), 455-62. 80.Desagher, S.; Osen-Sand, A.; Montessuit, S.; Magnenat, E.; Vilbois, F.; Hochmann, A.; Journot, L.; Antonsson, B.; Martinou, J. C., Phosphorylation of bid by casein kinases I and II regulates its cleavage by caspase 8. Mol Cell 2001, 8, (3), 601-11. 81.Chen, G.; Cao, P.; Goeddel, D. V., TNF-induced recruitment and activation of the IKK complex require Cdc37 and Hsp90. Mol Cell 2002, 9, (2), 401-10. 82.Subramanian, A.; Miller, D. M., Structural analysis of alpha-enolase. Mapping the functional domains involved in down-regulation of the c-myc protooncogene. J Biol Chem 2000, 275, (8), 5958-65.
|